Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG

The reality of MFN drug pricing is going to set in over 'next 18 months,' says Novartis CEO

Name: The reality of MFN drug pricing is going to set in over 'next 18 months,' says Novartis CEO
Uploaded: 2026-04-28T10:16:14.000Z
Duration: 2 min 23 s
Description: President Donald Trump's drug pricing policy will have a "significant" impact on drugmakers and patients over the longer term, says Novartis CEO Vas Narasimhan.

President Donald Trump's drug pricing policy will have a "significant" impact on drugmakers and patients over the longer term, says Novartis CEO Vas Narasimhan.

02:23

Tue, Apr 28 20266:16 AM EDT

Carolin Roth